BACKGROUND: Computer based treatment for depression and anxiety has been available for several years and has demonstrated useful clinical effects. Most existing computerized CBT products in the UK that are designed to treat depression and co-morbid anxiety require patients to visit a clinic and require staff input to manage the process. Such intervention adds to the costs and bottlenecks in delivering a clinically effective treatment with mass availability. Internet treatment options are becoming more readily available, although data to support use are not yet strong, and most still require human assessment and telephone support. Blues Begone is a new computerized CBT program that has been designed to be used at home with minimal human support. METHOD: This pilot project provides data from an open trial of Blues Begone with both primary and secondary care patients. RESULTS: One hundred patients started Blues Begone, 58 completed the program, 72% (n = 42) of completers achieved reliable change and (n = 36) 62% achieved both reliable and clinically significant change, and may be considered to have recovered by the end of the program. CONCLUSION: These data provide the first demonstration of the potential viability of Blues Begone as a home based computerized treatment for depression and anxiety.
BACKGROUND: Computer based treatment for depression and anxiety has been available for several years and has demonstrated useful clinical effects. Most existing computerized CBT products in the UK that are designed to treat depression and co-morbid anxiety require patients to visit a clinic and require staff input to manage the process. Such intervention adds to the costs and bottlenecks in delivering a clinically effective treatment with mass availability. Internet treatment options are becoming more readily available, although data to support use are not yet strong, and most still require human assessment and telephone support. Blues Begone is a new computerized CBT program that has been designed to be used at home with minimal human support. METHOD: This pilot project provides data from an open trial of Blues Begone with both primary and secondary care patients. RESULTS: One hundred patients started Blues Begone, 58 completed the program, 72% (n = 42) of completers achieved reliable change and (n = 36) 62% achieved both reliable and clinically significant change, and may be considered to have recovered by the end of the program. CONCLUSION: These data provide the first demonstration of the potential viability of Blues Begone as a home based computerized treatment for depression and anxiety.
Authors: Alba Lopez-Montoyo; Soledad Quero; Jesus Montero-Marin; Alberto Barcelo-Soler; Maria Beltran; Daniel Campos; Javier Garcia-Campayo Journal: BMC Psychiatry Date: 2019-10-16 Impact factor: 3.630
Authors: Yolanda López-del-Hoyo; Barbara Olivan; Juan V Luciano; Fermín Mayoral; Miquel Roca; Margalida Gili; Eva Andres; Antoni Serrano-Blanco; Francisco Collazo; Ricardo Araya; Rosa Baños; Cristina Botella; Rosa Magallón; Javier García-Campayo Journal: BMC Psychiatry Date: 2013-01-11 Impact factor: 3.630
Authors: Jesús Montero-Marín; José Miguel Carrasco; Miquel Roca; Antoni Serrano-Blanco; Margalida Gili; Fermin Mayoral; Juan V Luciano; Yolanda Lopez-del-Hoyo; Barbara Olivan; Francisco Collazo; Ricardo Araya; Rosa Baños; Cristina Botella; Javier García-Campayo Journal: BMC Psychiatry Date: 2013-02-20 Impact factor: 3.630
Authors: Jesús Montero-Marín; Ricardo Araya; María C Pérez-Yus; Fermín Mayoral; Margalida Gili; Cristina Botella; Rosa Baños; Adoración Castro; Pablo Romero-Sanchiz; Yolanda López-Del-Hoyo; Raquel Nogueira-Arjona; Margarita Vives; Antoni Riera; Javier García-Campayo Journal: J Med Internet Res Date: 2016-08-26 Impact factor: 5.428